Adaptive Biotechnologies President and COO Julie Rubinstein reports sale of $928,891.41 in common shares
ADPT•Julie Rubinstein sold 35,643 Adaptive Biotechnologies common shares from Oct. 30 through Nov. 3, 2026, for reported prices of $25.23 to $27.45 per share. She exercised options for the same number of shares at $12.14 each.
1. Share transactions
Adaptive Biotechnologies President and COO Julie Rubinstein sold 35,643 common shares from Oct. 30 through Nov. 3, 2026, at reported prices ranging from $25.23 to $27.45 per share. Over the same period, she exercised options for 35,643 shares at $12.14 per share; after the transactions, she directly held 377,802 common shares and 94,633 stock options.
